Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aptose Biosciences Inc (APS.TO)

Aptose Biosciences Inc (APS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aptose Biosciences Inc 251 Consumers Road Suite 1105 Toronto ON M2J 4R3 CAN

https://www.aptose.com P: 647-479-9828

Description:

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Key Statistics

Overview:

Market Capitalization, $K 25,934
Shares Outstanding, K 15,718
Annual Sales, $ 0 K
Annual Net Income, $ -51,207 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -11,955 K
60-Month Beta 1.13
% of Institutional Shareholders 0.02%

Growth:

1-Year Return -83.23%
3-Year Return -98.41%
5-Year Return -96.39%
5-Year Revenue Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/13/24
Earnings Per Share ttm -7.58
EPS Growth vs. Prev Year 14.37%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 06/06/23

APS.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -293.96%
Return-on-Assets % -159.98%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book N/A
Book Value/Share -0.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar